Affiliation:
1. the Divisions of Cardiovascular Diseases and Internal Medicine (R.B.M., R.A.N., A.J.T.) and Thoracic and Cardiovascular Surgery (H.V.S., G.K.D.), Mayo Clinic and Mayo Foundation, Rochester, Minn.
Abstract
Background
A subgroup of patients with hypertrophic obstructive cardiomyopathy remain severely symptomatic despite optimal medical therapy. Septal myectomy reduces or eliminates left ventricular outflow obstruction and produces marked symptomatic improvement. With the recent advent of alternative methods for treatment of this disorder, such as dual-chamber pacing, it is necessary to establish the risks and benefits of septal myectomy in the modern surgical era.
Methods and Results
The clinical, ECG, echocardiographic, cardiac catheterization, and surgical data were analyzed for 65 patients 20 to 70 years old with hypertrophic obstructive cardiomyopathy who had surgical treatment between 1986 and 1992. Specific symptoms and overall functional status were evaluated before surgery and at the end of the first postoperative year. Subsequent long-term clinical postoperative follow-up was also obtained. The extent of postoperative improvement was measured by the presence and severity of persistent symptoms, overall New York Heart Association (NYHA) functional class, and patients' self-perceptions of overall improvement. Of the patients, 95% were in NYHA functional class III or IV before surgery: 95% had dyspnea, 62% had angina, 63% had near-syncope, and 23% had syncope. The overall early mortality rate was 4.6%; there was no mortality among the 45 patients who underwent isolated septal myectomy. At the 1-year postoperative evaluation, 89% of survivors were in NYHA functional class I or II, and 47% believed that they had 100% improvement. Significant improvement (as defined) was seen in 67% of patients with dyspnea, 90% with angina, 86% with near-syncope, and 100% with syncope. The 5-year survival rate was 92%.
Conclusions
The results of the present study reaffirm the efficacy of surgical treatment of hypertrophic obstructive cardiomyopathy in patients who are severely symptomatic despite optimal medical therapy and serve as a useful reference by which the surgical approach can be compared with new and potentially promising treatment alternatives.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Reference20 articles.
1. Idiopathic hypertrophic subaortic stenosis
2. The outcome of surgical treatment of hypertrophic obstructive cardiomyopathy
3. Williams WG Wigle ED Rakowski H Smallhorn J LeBlanc J Trusler GA. Results of surgery for hypertrophic obstructive cardiomyopathy. Circulation . 1987;76(suppl V):V-104-V-108.
4. Morrow AG Epstein SE Rodgers BM Braunwald E. Idiopathic hypertrophic subaortic stenosis: a current assessment of the results of operative treatment. In: Wolstenholme GEW O'Connor M eds. Hypertrophic Obstructive Cardiomyopathy . London UK: Churchill Livingstone; 1971:140-149.
Cited by
195 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献